Hematology Transfusion and Cell Therapy
Scope & Guideline
Innovating the future of blood disorder management.
Introduction
Aims and Scopes
- Hematological Disorders:
The journal covers a wide range of hematological conditions, including leukemias, lymphomas, myelomas, and other blood disorders, emphasizing both clinical and laboratory research. - Transfusion Medicine:
Research related to blood transfusion practices, safety, and efficacy, including studies on blood components, transfusion reactions, and management protocols. - Cell Therapy and Stem Cell Transplantation:
Focus on advancements in cell therapies, including hematopoietic stem cell transplantation techniques, outcomes, and challenges, particularly in resource-limited settings. - Infectious Complications in Hematology:
Exploration of infectious risks associated with hematological diseases and treatments, particularly in the context of COVID-19 and other emerging infections. - Genetic and Molecular Studies:
Research investigating genetic factors influencing hematological diseases, including molecular diagnostics, biomarkers for disease prognosis, and treatment responses. - Patient Management and Quality of Life:
Studies addressing patient care strategies, including management of symptoms, side effects of treatments, and overall patient quality of life in hematological settings.
Trending and Emerging
- Impact of COVID-19 on Hematology:
A significant increase in research addressing the effects of COVID-19 on patients with hematological conditions, including complications, treatment adaptations, and vaccination responses. - Personalized Medicine and Targeted Therapies:
Growing emphasis on studies exploring personalized treatment approaches in hematology, particularly the use of genetic markers for tailoring therapies. - Patient Blood Management Strategies:
Emerging focus on optimizing blood use in clinical settings, including protocols for minimizing transfusions and improving patient outcomes. - Innovations in Cell Therapy:
Increased interest in novel cell therapies, including CAR-T cell therapy and other advanced therapeutic modalities targeting hematological malignancies. - Health Equity and Access to Care:
Research highlighting disparities in healthcare access and outcomes for hematology patients, particularly in low- and middle-income countries. - Quality of Life Assessments:
Growing trend towards evaluating the quality of life and psychosocial impacts of hematological diseases and treatments, reflecting a holistic approach to patient care.
Declining or Waning
- Traditional Hematology Techniques:
There is a noticeable decrease in studies focusing solely on traditional hematological laboratory techniques, as advancements in molecular and genetic diagnostics gain prominence. - Basic Science Research:
Research that does not directly translate to clinical application is becoming less frequent, as the journal emphasizes studies with immediate clinical relevance. - Historical Perspectives on Hematology:
Papers focusing on historical analyses or reviews of past practices in hematology are becoming less common, reflecting a shift towards contemporary issues and innovations.
Similar Journals
Transfusionsmedizin
Exploring the forefront of transfusion therapy advancements.Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.
Indian Journal of Hematology and Blood Transfusion
Fostering Collaboration in Hematology and Transfusion MedicineIndian Journal of Hematology and Blood Transfusion, published by SPRINGER INDIA, serves as a leading platform for disseminating original research, reviews, and case studies in the field of hematology. With an ISSN of 0971-4502 and E-ISSN 0974-0449, this journal has been instrumental in advancing knowledge from 2000 to 2024, providing insights into critical issues surrounding blood disorders and transfusion practices. Currently ranked in the Q3 category for Hematology for 2023, it reflects a commitment to high-quality scientific content amidst a competitive landscape where it ranks 97/137 in Scopus for Medicine - Hematology, placing it in the 29th percentile of its peers. The journal primarily addresses a diverse readership, including researchers, healthcare professionals, and students, aiming to foster innovation and collaboration within the field. Although it operates under a subscription model, access options for individual articles and institutional subscriptions ensure that valuable research is disseminated widely to enhance medical practice and education in hematology.
Turkish Journal of Hematology
Championing open access to vital hematology knowledge.Turkish Journal of Hematology is an esteemed publication dedicated to advancing the field of hematology, producing influential research since its inception in 1999 under the auspices of GALENOS PUBL HOUSE. With an Open Access model, it facilitates widespread dissemination of knowledge, allowing researchers, clinicians, and students to stay abreast of the latest developments in blood disorders and treatments. With an ISSN of 1300-7777 and an E-ISSN of 1308-5263, the journal holds a commendable position in the academic community, evidenced by its 2023 Q3 ranking within the hematology category and its standing at #80 out of 137 in the Scopus database, placing it in the 41st percentile. Covering a wide scope of topics within hematology, this journal serves as a critical resource for disseminating innovative research and clinical practices pertinent to the ongoing challenges faced in this vital area of medicine. With its continuous publication until 2024, Turkish Journal of Hematology remains a beacon for enhancing the understanding and treatment of hematological conditions within the Turkish and global medical communities.
TRANSFUSION AND APHERESIS SCIENCE
Fostering Collaboration and Innovation in Blood HealthTRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.
TRANSFUSION MEDICINE REVIEWS
Elevating clinical practices through evidence-based reviews.TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.
TRANSFUSION MEDICINE AND HEMOTHERAPY
Empowering innovation in hematology and transfusion medicine.TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.
Journal of Hematology
Empowering Research, Transforming LivesThe Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.
VOX SANGUINIS
Fostering Collaboration in Hematological ResearchVOX SANGUINIS is a distinguished peer-reviewed journal in the fields of Hematology and Medicine, published by Wiley, a leading academic publisher based in the United Kingdom. With a rich history dating back to its inception in 1952, this journal has consistently provided a platform for innovative research and insightful reviews, advancing the understanding of blood-related disorders and therapies. As evidenced by its robust performance—ranking #57 out of 137 in Scopus for Medicine in Hematology and holding a Q2 classification in both Hematology and miscellaneous Medicine categories—VOX SANGUINIS is recognized for its significant contributions to the scientific community. This journal serves as a vital resource for researchers, professionals, and students alike, fostering knowledge exchange and collaboration within the field. With its ongoing commitment to quality and integrity, VOX SANGUINIS continues to shape the future of hematological research well into 2024 and beyond.
INTERNATIONAL JOURNAL OF HEMATOLOGY
Fostering Global Insights in Blood ResearchThe INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.
Blood Transfusion
Advancing the Science of Blood Transfusion.Blood Transfusion is a leading journal in the fields of Hematology, Immunology, and Medicine, published by SIMTIPRO SRL in Italy. With its ISSN 1723-2007, the journal has established a significant presence in the academic community, as evidenced by its positioning within the Q2 category in Hematology and Medicine (miscellaneous) and Q3 in Immunology and Allergy for 2023. Notably, it ranks #38 out of 137 in the Hematology category, showcasing its impactful contributions to research and practice. Operating under a traditional publishing model, this journal provides valuable insights into advances in blood transfusion science, ultimately aimed at enhancing patient care and outcomes. Spanning from 2003 to 2024, the scope of Blood Transfusion covers a wide range of topics related to hematological and immunological research, making it an essential resource for researchers, healthcare professionals, and students engaged in these critical fields.